Open Access
Volume 29, 2022
Article Number 52
Number of page(s) 11
Published online 09 November 2022
  1. Armengol C, Cassaing S, Roques-Malecaze C, Chauvin P, Iriart X, Berry A, Fillaux J. 2017. Time before anti-Toxoplasma IgG seroconversion detection by 7 commercial assays in French pregnant women. Diagnostic Microbiology and Infectious Disease, 87, 103–107. [CrossRef] [PubMed] [Google Scholar]
  2. Aubert D, Maine GT, Villena I, Hunt JC, Howard L, Sheu M, Brojanac S, Chovan LE, Nowlan SF, Pinon JM. 2000. Recombinant antigens to detect Toxoplasma gondii -specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. Journal of Clinical Microbiology, 38, 1144–1150. [CrossRef] [PubMed] [Google Scholar]
  3. Dard C, Bailly S, Drouet T, Fricker-Hidalgo H, Brenier-Pinchart M, Pelloux H. 2017. Long-term sera storage does not significantly modify the interpretation of toxoplasmosis serologies. Journal of Microbiological Methods, 134, 38–45. [CrossRef] [PubMed] [Google Scholar]
  4. Dard C, Fricker-Hidalgo H, Brenier-Pinchart M-P, Pelloux H. 2016. Relevance of and new developments in serology for toxoplasmosis. Trends in Parasitology, 32, 492–506. [CrossRef] [PubMed] [Google Scholar]
  5. Dupont D, Fricker-Hidalgo H, Brenier-Pinchart M-P, Garnaud C, Wallon M, Pelloux H. 2021. Serology for Toxoplasma in immunocompromised patients: still useful? Trends in Parasitology, 37, 205–213. [CrossRef] [PubMed] [Google Scholar]
  6. Franck J, Garin YJ-F, Dumon H. 2008. LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti- Toxoplasma antibody detection. Journal of Clinical Microbiology, 46, 2334–2338. [CrossRef] [PubMed] [Google Scholar]
  7. Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L’Ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H. 2013. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study. Journal of Clinical Microbiology, 51, 2103–2111. [CrossRef] [PubMed] [Google Scholar]
  8. Fricker-Hidalgo H, Bailly S, Brenier-Pinchart M-P, Dard C, Jean D, Coston A-L, Garnaud C, Pelloux H. 2020. How to estimate time of infection with Toxoplasma gondii in pregnant women. Use of specific IgG and IgM kinetics by 7 techniques on 691 sera. Diagnostic Microbiology and Infectious Disease, 96. [Google Scholar]
  9. Gay-Andrieu F, Fricker-Hidalgo H, Sickinger E, Espern A, Brenier-Pinchart M-P, Braun H-B, Pelloux H. 2009. Comparative evaluation of the ARCHITECT Toxo IgG, IgM, and IgG Avidity assays for anti-Toxoplasma antibodies detection in pregnant women sera. Diagnostic Microbiology and Infectious Disease, 65, 279–287. [CrossRef] [PubMed] [Google Scholar]
  10. Gilbert R. 2009. Treatment for congenital toxoplasmosis: finding out what works. Memórias do Instituto Oswaldo Cruz, 104, 305–311. [CrossRef] [PubMed] [Google Scholar]
  11. Hotop A, Hlobil H, Gross U. 2012. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clinical Infectious Diseases, 54, 1545–1552. [CrossRef] [PubMed] [Google Scholar]
  12. Jones JL, Dubey JP. 2012. Foodborne toxoplasmosis. Clinical Infectious Diseases, 55, 845–851. [CrossRef] [PubMed] [Google Scholar]
  13. Jost C, Touafek F, Fekkar A, Courtin R, Ribeiro M, Mazier D, Paris L. 2011. Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women. Clinical and Vaccine Immunology, 18, 1908–1912. [CrossRef] [PubMed] [Google Scholar]
  14. Khammari I, Saghrouni F, Lakhal S, Bouratbine A, Ben Said M, Boukadida J. 2014. A new IgG immunoblot kit for diagnosis of toxoplasmosis in pregnant women. Korean Journal of Parasitology, 52, 493–499. [CrossRef] [Google Scholar]
  15. Khammari I, Saghrouni F, Yaacoub A, Gaied Meksi S, Ach H, Garma L, Fathallah A, Ben Saïd M. 2013. IgG Western blot for confirmatory diagnosis of equivocal cases of toxoplasmosis by EIA-IgG and fluorescent antibody test. Korean Journal of Parasitology, 51, 485–488. [CrossRef] [Google Scholar]
  16. Landis JR, Koch GG. 1977. Measurement of observer agreement for categorical data. Biometrics, 33, 159. [CrossRef] [Google Scholar]
  17. Leslé F, Touafek F, Fekkar A, Mazier D, Paris L. 2011. Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: interest of Toxo IgG Western blot. European Journal of Clinical Microbiology & Infectious Diseases, 30, 1207–1212. [CrossRef] [PubMed] [Google Scholar]
  18. Maudry A, Chene G, Chatelain R, Patural H, Bellete B, Tisseur B, Hafid J, Raberin H, Beretta S, Tran Manh Sung R, Belot G, Flori P. 2009. Bicentric evaluation of six anti-Toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot. Clinical and Vaccine Immunology, 16, 1322–1326. [CrossRef] [PubMed] [Google Scholar]
  19. Meroni V, Genco F, Scudeller L, Brenier-Pinchart M-P, Fricker-Hidalgo H, L’Ollivier C, Paris L, Pelloux H. 2022. Diagnostic accuracy of LDBIO-Toxo II IgG and IgM Western blot in suspected seroconversion in pregnancy: a multicentre study. Pathogens, 11, 665. [CrossRef] [PubMed] [Google Scholar]
  20. Murat J-B, Dard C, Fricker Hidalgo H, Dardé M-L, Brenier-Pinchart M-P, Pelloux H. 2013. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Clinical and Vaccine Immunology, 20, 1203–1212. [Google Scholar]
  21. Murat J-B, Fricker Hidalgo H, Brenier-Pinchart M-P, Pelloux H. 2013. Human toxoplasmosis: Which biological diagnostic tests are best suited to which clinical situations? Expert Review of Anti-Infective Therapy, 11, 943–956. [CrossRef] [PubMed] [Google Scholar]
  22. Pfrepper K-I, Enders G, Gohl M, Krczal D, Hlobil H, Wassenberg D, Soutschek E. 2005. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clinical Diagnostic Laboratory Immunology, 12, 977–982. [Google Scholar]
  23. Pietkiewicz H, Hiszczynska-Sawicka E, Kur J, Petersen E, Nielsen HV, Stankiewicz M, Andrzejewska I, Myjak P. 2004. Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. Journal of Clinical Microbiology, 42, 1779–1781. [CrossRef] [PubMed] [Google Scholar]
  24. Reiter-Owona I, Petersen E, Joynson D, Grillo R, Gross U, Hayde M, Holliman R, Ho-Yen DO, Janitschke K, Jenum PA, Naser K, Olszewski M, Thulliez P, Seitz HM. 1999. Past and present role of the Sabin ± Feldman dye test in the serodiagnosis of toxoplasmosis. Bulletin of the World Health Organization, 77, 929–935. [PubMed] [Google Scholar]
  25. Robert-Gangneux F, Dardé M-L. 2012. Epidemiology of and diagnostic strategies for toxoplasmosis. Clinical Microbiology Reviews, 25, 264–296. [CrossRef] [PubMed] [Google Scholar]
  26. Robert-Gangneux F, Guegan H. 2021. Anti-Toxoplasma IgG assays: What performances for what purpose? A systematic review Parasite, 28, 39. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  27. Roux-Buisson N, Fricker-Hidalgo H, Foussadier A, Rolland D, Suchel-Jambon A-S, Brenier-Pinchart M-P, Pelloux H. 2005. Comparative analysis of the VIDAS Toxo IgG IV assay in the detection of antibodies to Toxoplasma gondii. Diagnostic Microbiology and Infectious Disease, 53, 79–81. [CrossRef] [PubMed] [Google Scholar]
  28. Sensini A. 2006. Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clinical Microbiology and Infection, 12, 504–512. [CrossRef] [PubMed] [Google Scholar]
  29. Sickinger E, Gay-Andrieu F, Jonas G, Schultess J, Stieler M, Smith D, Hausmann M, Stricker R, Stricker R, Dhein J, Braun H-B. 2008. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Diagnostic Microbiology and Infectious Disease, 62, 235–244. [CrossRef] [PubMed] [Google Scholar]
  30. Simon L, Fillaux J, Guigon A, Lavergne R-A, Villard O, Villena I, Marty P, Pomares C, Toxoplasma p35 Study Group. 2020. Serological diagnosis of Toxoplasma gondii : analysis of false-positive IgG results and implications. Parasite, 27, 7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  31. Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. 2016. Help in the choice of automated or semiautomated immunoassays for serological diagnosis of toxoplasmosis: evaluation of nine immunoassays by the French national reference center for toxoplasmosis. Journal of Clinical Microbiology, 54, 3034–3042. [CrossRef] [PubMed] [Google Scholar]
  32. Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. 2016. Serological diagnosis of Toxoplasma gondii infection. Diagnostic Microbiology and Infectious Disease, 84, 22–33. [CrossRef] [PubMed] [Google Scholar]
  33. Wallon M, Peyron F. 2016. Effect of antenatal treatment on the severity of congenital toxoplasmosis. Clinical Infectious Diseases, 62, 811–812. [Google Scholar]
  34. Weiss LM, Dubey JP. 2009. Toxoplasmosis: a history of clinical observations. International Journal for Parasitology, 39, 895–901. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.